The author team introduces the terms 'exozymes' to bring clarity to the rapidly evolving field of cell-free ...

Sana Biotechnology, Inc.’s SANA share price has surged by 7.80%, which has investors questioning if this is right time to sell.

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Ovo Labs has developed three therapeutic treatments that reduce genetic errors in eggs, “dramatically” boosting the chances ...

Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper Scientific definition ...

There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...

Brings important and complementary skills to support company's development ...

Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...

Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today announced the ...

Duyk said the $30 million in funding has helped Grove Biopharma expand from "about four people working on this" to a current ...

Story Feb. 3 - Omega Therapeutics: With cash running low, the Novo Nordisk-partnered biotech has struck a deal with its founder Flagship Pioneering that could see it file for bankruptcy and lay ...